M

MPM Capital portfolio

MPM Capital has 3 portfolio companies on record at Recent Funding. It led 3 of the 6 rounds it joined. Its most recent investment on record is Reunion Neuroscience's $133M Series A round in September 2025, which it led, alongside Plaisance Capital Management, Palo Santo Fund, Novo Holdings and 3 others. By category, its portfolio leans toward Health and bio (3) and Manufacturing and industrial (1). It has co-invested with Qiming Venture Partners USA, DCVC Bio and SoftBank Vision Fund, most often Qiming Venture Partners USA (3 rounds).

What MPM Capital invests in

• Health and bio · 3 · 100%
• Manufacturing and industrial · 1 · 33%

MPM Capital recent investments

Company	Round	Date	Alongside
RReunion Neuroscience	Series A · $133M · lead	Sep 16, 2025	Plaisance Capital Management, Palo Santo Fund, Novo Holdings (lead) +3
UUmoja Biopharma	Series B+ · $100M	Jan 14, 2025	SoftBank Vision Fund, RTW Investments, Qiming Venture Partners USA +6
AAktis Oncology	Series A · $84M	Aug 26, 2022	Vida Ventures, TCG Crossover, Pappas Capital +6
UUmoja Biopharma	Series B+ · $210M	Jun 15, 2021	Temasek, SVB Securities, SoftBank Vision Fund (lead) +6
AAktis Oncology	Series A · $72M · lead	Mar 18, 2021	Vida Ventures (lead), TCG Crossover, Octagon Capital Advisors +3
UUmoja Biopharma	Series A · $53M · lead	Nov 1, 2020	Qiming Venture Partners USA (lead), DCVC Bio

How MPM Capital invests

Share is of the 6 rounds on Recent Funding that name MPM Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

MPM Capital portfolio companies

• RReunion Neuroscience$133MSeries A · Sep 2025
• UUmoja Biopharma$100MSeries B+ · Jan 2025
• AAktis Oncology$84MSeries A · Aug 2022

Company	Round with MPM Capital	Total raised	Latest raise
RReunion Neuroscience Health and bio	Sep 16, 2025 Series A · $133M · lead	$133M	Sep 16, 2025 Series A
UUmoja Biopharma Health and bio	Jan 14, 2025 Series B+ · $100M	$363M	Jan 14, 2025 Series B+
AAktis Oncology Health and bio	Aug 26, 2022 Series A · $84M	$336M	Sep 1, 2024 Series B+

Most frequent co-investors

• QQiming Venture Partners USA3 shared rounds · last Jan 14, 2025
• DDCVC Bio3 shared rounds · last Jan 14, 2025
• SSoftBank Vision Fund2 shared rounds · last Jan 14, 2025
• EEmerson Collective2 shared rounds · last Jan 14, 2025
• RRTW Investments2 shared rounds · last Jan 14, 2025
• CCormorant Asset Management2 shared rounds · last Jan 14, 2025
• TTCG Crossover2 shared rounds · last Aug 26, 2022
• VVida Ventures2 shared rounds · last Aug 26, 2022
• OOctagon Capital Advisors2 shared rounds · last Aug 26, 2022
• NNovartis2 shared rounds · last Aug 26, 2022
• NNovo Holdings1 shared round · last Sep 16, 2025
• PPlaisance Capital Management1 shared round · last Sep 16, 2025

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• BBlue Cloud Ventures3 companies · 3 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo
• KKorea Credit Guarantee Fund3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists MPM Capital, which is a subset of its real portfolio. API: /api/v1/investors/mpm-capital (get a free API key). More: the most active VC firms and new venture capital funds.